kabutan

Fuji Pharma Co.,Ltd.(4554) Summary

4554
TSE Prime
Fuji Pharma Co.,Ltd.
1,770
JPY
+41
(+2.37%)
Dec 12, 3:30 pm JST
11.36
USD
Dec 12, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
11.3
PBR
0.92
Yield
2.66%
Margin Trading Ratio
20.40
Stock Price
Dec 12, 2025
Opening Dec 12, 9:00 am
1,743 JPY 11.20 USD
Previous Close Dec 11
1,729 JPY 11.07 USD
High Dec 12, 9:38 am
1,780 JPY 11.43 USD
Low Dec 12, 9:00 am
1,743 JPY 11.20 USD
Volume
76,800
Trading Value
0.14B JPY 0.87M USD
VWAP
1763.26 JPY 11.32 USD
Minimum Trading Value
177,000 JPY 1,136 USD
Market Cap
0.04T JPY 0.28B USD
Number of Trades
355
Liquidity & Number of Trades
As of Dec 12, 2025
Liquidity
Mid
1-Year Average
306
1-Year High Feb 7, 2025
1,184
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 5, 2025 15,300 190,400 12.44
Nov 28, 2025 18,500 305,300 16.50
Nov 21, 2025 24,800 288,300 11.63
Nov 14, 2025 18,900 261,300 13.83
Nov 7, 2025 19,300 265,000 13.73
Company Profile
Fuji Pharma Co., Ltd. is a leading generic pharmaceutical company, specializing in fertility treatments and contrast agents. The company is also expanding into new drugs and biosimilars.
Sector
Pharmaceuticals
Fuji Pharma Co., Ltd. is a major generic drug manufacturer, primarily focusing on injectable products such as hormone preparations for obstetrics and gynecology, and urinary tract and vascular contrast agents for radiology. The company operates through five branch offices nationwide, engaging in the development, manufacturing, and sales of pharmaceuticals. With one consolidated subsidiary, Fuji Pharma conducts product trading and financial lending with its Thai subsidiary. Operating under a single pharmaceutical business segment, the company offers a diverse product lineup to meet a wide range of medical needs. As a pharmaceutical manufacturer with particular strengths in obstetrics, gynecology, and radiology, Fuji Pharma Co., Ltd. conducts business both domestically and internationally.